Pfizer at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Pfizer brings 5 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 601, Suite 20, Suite 20a, Suite 21, Suite 21a. Its program spans early lab work on obesity drug targets, including a small-molecule GIPR blocker and how muscle responds to GLP-1 drugs in mice, plus heart and metabolic risk markers with monthly berobenatide. It also covers AI-assisted algorithms that detect meals from continuous glucose monitor data.

OrganizationObesityWeek 2026 Attendance
Pfizer
New York, NY
◇Bronze Sponsor
Large pharmaBronze Sponsor
Global drugmaker that discovers, develops and manufactures medicines and vaccines across many diseases.
Booth
Exhibiting at Booth 601, Suite 20, Suite 20a, Suite 21, Suite 21a
Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm
Poster
Sat Nov 14
7:30pm–8:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Pfizer

Tell us what you sell and we’ll find the people at Pfizer most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction